tradingkey.logo

ReShape Lifesciences Inc

RSLS
View Detailed Chart
3.920USD
0.000
Market hours ETQuotes delayed by 15 min
10.29MMarket Cap
LossP/E TTM

ReShape Lifesciences Inc

3.920
0.000
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

0.00%

1 Month

0.00%

6 Months

-62.67%

Year to Date

-96.48%

1 Year

-97.41%

View Detailed Chart

TradingKey Stock Score

No scoring data

ReShape Lifesciences Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

ReShape Lifesciences Inc Info

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Ticker SymbolRSLS
CompanyReShape Lifesciences Inc
CEOMr. Paul F. Hickey
Websitehttps://www.reshapelifesciences.com/obalon/
KeyAI